NEW YORK (GenomeWeb) – Vermillion reported after the close of the market on Monday a more-than-threefold increase in its first quarter revenues. 

For the three months ended March 31, the Austin, Texas-based bioanalytical solutions firm said that total revenues rose to $951,000 from $305,000 in the year-ago quarter. 

The firm notched $635,000 in product revenues, up from $191,000 in Q1 2014, and $316,000 in license revenues, up from $114,000 a year ago. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.